Alcon’s Post

Ophthalmic Lasers Market2 PORTLAND, OR, UNITED STATES, July 21, 2023/EINPresswire.com/ -- Allied Market Research has recently published the latest research study titled "Global Ophthalmic Lasers Market: Outlook and Forecast 2023-2030." This comprehensive report includes an evaluation of market risk through side analysis while highlighting opportunities and providing strategic and tactical decision-making support for the period between 2023 and 2030. The market study is segmented by key regions that are driving the marketization process. The report offers valuable insights into market research and development, growth drivers, and the evolving investment structure of the Global Ophthalmic Lasers Market. Among the key players profiled in this study are Carl-Zeiss-Stiftung, Iridex, Johnson & Johnson, LightMed, Lumenis Be, Lumibird Group, NIDEK, Novartis International, Topcon, and Ziemer Ophthalmic DreamGalaxy+ News: See Yourself in Educational Global Media from XR to NFTs and beyond! https://lnkd.in/e3ec6uKp

https://lnkd.in/dM5qwBvC Key Insights: • Asensus and NVIDIA intend to collaborate in defining inventive business models for the creation, implementation, and promotion of digital surgical solutions Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #drugapproval #HealthTrends #Insights #HealthIndustry #HealthInnovation #surgical #nvidia #collaboration #HealthcareAnalytics #NewsUpdate #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights

What makes CEQUA® (cyclosporine ophthalmic solution) 0.09% (Sun Ophthalmics) so unique? A group of experts sat down to explore this question, analyze clinical trial data, and discuss the safety and tolerability profile of CEQUA. https://bit.ly/4cA1kmI

Vertebral Compression Fracture Treatment Enhanced by Medtronic and Merit Medical Systems, Inc. Collaboration Medtronic and Merit Medical Systems, Inc. have partnered to distribute the Kyphon KyphoFlex unipedicular balloon catheter in the U.S., enhancing vertebral compression fracture (VCF) treatments. The Kyphon KyphoFlex catheter, designed for precise cavity creation using orthopedic balloons, treats VCFs caused by osteoporosis, cancer, or benign lesions. Medtronic will handle sales and marketing, while Merit Medical Systems, Inc. oversees manufacturing and regulatory compliance. This collaboration leverages the strengths of both companies to provide a steerable solution for targeted vertebral augmentation, aiming to improve patient outcomes and quality of life. For more details please click the link! https://lnkd.in/greG5yhE #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

📢 Boston Scientific to buy neuromodulation company Axonics, Inc. for $3.7bn Under the terms of the agreement, Boston Scientific will purchase all the shares of Axonics, Inc. for $71 in cash per share, which is a 23.3% premium to Axonics, Inc.’ share price at last closing. Axonics, Inc. is a medical technology company primarily engaged in the development and marketing of different medical devices to treat urinary and bowel dysfunction. The company develops sacral neuromodulation (SNM) therapy for bladder and bowel dysfunction and urethral bulking for women with stress urinary incontinence. The boards of directors of both companies have unanimously approved the transaction. It is expected to be completed in the first half of 2024, subject to certain customary closing conditions, including Axonics, Inc.’ stockholders’ approval and regulatory approvals. Upon completion of the transaction, Axonics, Inc. will become a fully-owned subsidiary of Boston Scientific. Through the acquisition, Boston Scientific will enter the area of SNM therapy, a minimally invasive procedure used to treat overactive bladder (OAB) and faecal incontinence. Boston Scientific Urology senior vice president and president Meghan Scanlon said: “We are excited to add Axonics technologies to the Boston Scientific portfolio, a combination that we expect will further strengthen our ability to serve urologists who are treating patients living with these often-chronic conditions. “This acquisition also enables our entry into sacral neuromodulation, a high-growth adjacency with opportunities to expand access to care for patients.” Read more online: bit.ly/3NXQJYe 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #bostonscientific #axonics

#Shoulder_Arthroscopy Market Key Players Analysis and Forecast To 2030 by Value Market Research >> https://lnkd.in/dfd2cdE5 Shoulder #Arthroscopy, a minimally invasive #surgical procedure, is employed for both the #diagnosis and treatment of various #conditions affecting the #shoulder joint. It utilizes a miniature #camera known as an #arthroscope, which is introduced through #minor incisions around the shoulder #joint. KARL STORZ Biotek Ortho CONMED Corporation STAR Sports Medicine Osteocare Medical Arthrex Johnson & Johnson Stryker GPC Medical Ltd. #technologies #marketgrowth #innovationmanagement #healthcareindustry #pharmaceuticalindustry #arthroscopy #treatments #joint

📣 CartiHeal, a revolutionary #MedTech company, has been acquired by Smith+Nephew for up to $330 million. According to Altschuler, “The CartiHeal implant, defined by the #FDA as a breakthrough technology, is extracted from the calcium of corals and is surgically implanted by orthopedic surgeons into the infected area. The company received FDA approval in March 2022, after completing a clinical trial that lasted several years and included hundreds of patients in 26 centers in the U.S., Europe, and Israel. The trial showed the distinct advantages of the implant over existing procedures, including the ability to regrow cartilage.” “The acquisition of this disruptive technology supports our strategy to invest behind our successful Sports Medicine business”, said Deepak Nath Chief Executive Officer of Smith+Nephew. We couldn't be more excited about the possibilities this partnership brings. 🚀 Read more here: https://lnkd.in/dJ_RyUX5 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/d_yMAmCr #MedicalTechnology #JointRepair #OrthopedicCare #GuidedSolutions

𝗦𝗽𝗼𝗿𝘁𝘀 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁𝗲𝗱 𝘁𝗼 𝗪𝗼𝗿𝘁𝗵 $7.2 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 2025 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲-https://lnkd.in/dsWnBA7r The size of global sports medicine market in terms of revenue was estimated to be worth $5.5 billion in 2020 and is poised to reach $7.2 billion by 2025, growing at a CAGR of 5.7% from 2020 to 2025. 𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 - Arthrex - Smith+Nephew - Medtronic - Wright Medical Group N.V. - Bioventus - Stryker - Mueller Sports Medicine, Inc. - RTI Surgical Holdings, Inc - Breg - CONMED Corporation - Bauerfeind AG - KARL STORZ - Zimmer Biomet